RJA
CLOV icon

Raymond James & Associates’s Clover Health Investments CLOV Stock Holding History

Raymond James & Associates’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-31,500
Closed -$16K – 4107
2021
Q1 		$16K Buy
+31,500
New +$355K ﹤0.01% 3929

Other funds holding CLOV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
JAM
Jupiter Asset Management London, United Kingdom $18.8B AUM 29.2% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Raymond James & Associates's CLOV Position: Q2 2022 in Review

Raymond James & Associates sold out of Clover Health Investments (CLOV) in Q2 2022, closing a stake of 11,040 shares — an estimated $39K sold.

Raymond James & Associates first reported a position in CLOV in Q2 2020 and held it in 6 quarters. The position peaked at $1.8M in Q4 2020. 176 funds tracked by Wall St. Rank hold CLOV as of Q2 2022.

  • Raymond James & Associates reported no remaining Clover Health Investments position as of Q2 2022 after selling out during the quarter.
  • Raymond James & Associates sold 11,040 Clover Health Investments shares in Q2 2022, an estimated $39K.
  • Raymond James & Associates first reported a position in Clover Health Investments in Q2 2020 and held it in 6 quarters.
  • Raymond James & Associates's Clover Health Investments position peaked at $1.8M in Q4 2020.
  • 176 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2022.

Based on Raymond James & Associates's 13F filing for Q2 2022, filed 12 Aug 2022.